UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045641
Receipt number R000052105
Scientific Title Observational study of gut microbiota diversity in patients with long-term enteral nutrition
Date of disclosure of the study information 2021/10/07
Last modified on 2021/10/02 14:20:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study of gut microbiota diversity in patients with long-term enteral nutrition

Acronym

Observational study of gut microbiota diversity in patients with long-term enteral nutrition

Scientific Title

Observational study of gut microbiota diversity in patients with long-term enteral nutrition

Scientific Title:Acronym

Observational study of gut microbiota diversity in patients with long-term enteral nutrition

Region

Japan


Condition

Condition

persistent vegetative state patients

Classification by specialty

Hepato-biliary-pancreatic surgery Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether the diversity of the intestinal flora is reduced in patients with long-term bed rest and long-term enteral nutritional management due to persistent vegetative disorder compared to healthy subjects. In addition, the relationship between changes in the intestinal flora over time and changes in organic acids and bile acids in the body, changes in the level of consciousness disorder, susceptibility to infection, and changes in the level of consciousness disorder will be investigated.

Basic objectives2

Others

Basic objectives -Others

diversity of microbiota in persistent vegetative state patients

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

diversity of microbiota in persistent vegetative state patients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who participated in this study and obtained written consent by the free will of their families after receiving sufficient explanation and with sufficient understanding.
Patients between the ages of 20 and 80 at the time of consent

Key exclusion criteria

Patients who are also taking antibiotics
In addition, patients who are judged to be inappropriate by the principal investigator and the research coordinator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name ISAO
Middle name
Last name MORITA

Organization

Fujita Health University

Division name

neuro surgery

Zip code

4701192

Address

kutukake-cho dengakugakubo 1-98 Toyoake city Aichi Pref

TEL

0562932000

Email

iokuma@fujita-hu.ac.jp


Public contact

Name of contact person

1st name HIROSHI
Middle name
Last name MATSUOKA

Organization

Fujita Health University

Division name

gastroenterological surgery

Zip code

4701192

Address

kutukake-cho dengakugakubo 1-98 Toyoake city Aichi Pref

TEL

0562932000

Homepage URL


Email

mats1025@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health Univ Hospital

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University neurosurgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University IRB

Address

kutukake-cho dengakugakubo 1-98 Toyoake city Aichi Pref

Tel

0562932000

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 03 Month 31 Day

Date of IRB

2020 Year 05 Month 22 Day

Anticipated trial start date

2021 Year 03 Month 15 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing


Management information

Registered date

2021 Year 10 Month 02 Day

Last modified on

2021 Year 10 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052105